Suzanne Murphy

Cambridge University Hospitals NHS Foundation Trust

Papers

1

Total Citations

3

H-Index

1

About

Dr. Suzanne Murphy is a pioneering surgical oncologist whose research focuses on improving outcomes for patients with advanced melanoma through minimally invasive surgical techniques. Her major contributions center on the refinement and validation of robot-assisted pelvic lymph node dissection (rPLND), demonstrating that this approach offers superior recovery profiles—including reduced hospital stays and postoperative complications—while maintaining oncological equivalence to traditional open surgery. Her landmark 2024 study on robot-assisted pelvic dissection for enlarged lymph nodes in melanoma has already garnered 3 citations, establishing a new benchmark for surgical management in this challenging patient population. Dr. Murphy’s work is particularly significant given the evolving landscape of melanoma treatment, where effective systemic therapies are changing surgical indications. By rigorously comparing robotic and open approaches, she provides critical evidence that enables surgeons to offer less invasive options without compromising cancer control. Her research directly addresses the pressing clinical need to balance aggressive disease management with quality of life, making her a leading voice in the integration of advanced surgical technology into oncological practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Pelvic Dissection for Enlarged Lymph Nodes in Melanoma Improves Recovery with Equivalent Oncological Outcomes to Open Pelvic Dissection
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Cambridge University Hospitals NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago